BCTXL logo

BCTXLBriaCell Therapeutics Corp - Warrants (15/01/2031)

$0.6999
$0.03
(4.11%)
Today
Updated: 03:59 PM EDT
Vol20,474.00

About

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for BriaCell Therapeutics Corp - Warrants (15/01/2031)?
What is the 52-week low for BriaCell Therapeutics Corp - Warrants (15/01/2031)?
What is BriaCell Therapeutics Corp - Warrants (15/01/2031) stock price today?
What was BriaCell Therapeutics Corp - Warrants (15/01/2031) stock price yesterday?
What is the 50-day moving average of BriaCell Therapeutics Corp - Warrants (15/01/2031)?

Latest BCTXL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.